NorthCrest Asset Manangement’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
NorthCrest Asset Manangement's IBB Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its iShares Biotechnology ETF (IBB) stake by 17% in Q2 2026, buying an estimated $51.6K and bringing the position to 2,018 shares worth $398K. The position accounts for 0.01% of the portfolio, ranked #626.
NorthCrest Asset Manangement first reported a position in IBB in Q4 2021 and has held it in 17 quarters since. The position peaked at $611K in Q1 2023. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- NorthCrest Asset Manangement held 2,018 shares of iShares Biotechnology ETF worth $398K as of Q2 2026.
- NorthCrest Asset Manangement bought 300 iShares Biotechnology ETF shares in Q2 2026, an estimated $51.6K.
- iShares Biotechnology ETF made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #626 holding.
- NorthCrest Asset Manangement first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 17 quarters since.
- NorthCrest Asset Manangement's iShares Biotechnology ETF position peaked at $611K in Q1 2023.
- 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.